Oklahoma University Health Sciences Center

Oklahoma City, Oklahoma 73170

3 studies enrolling now · 25 studies all time

What they study most

Advanced Ovarian Cancer, Advanced Solid Tumors, Age-related Macular Degeneration, Aneurysmal Subarachnoid Hemorrhage, Atopic Dermatitis, Atrial Fibrillation, Bladder Cancer, Cerebral Aneurysm, Cervical Cancer, Colorectal Cancer, Crohn Disease, Deep Venous Thrombosis

Studies at this site

• A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors — Recruiting now
• Phase I Open-Label Randomized Multicenter Study of XNW28012 Monotherapy in Metastatic Pancreatic Cancer — Starting soon
• Eating, Sleeping, Consoling for Neonatal Withdrawal (ESC-NOW): a Function-Based Assessment and Management Approach — Completed
• ReCLAIM-2 Study to Evaluate Safety,Efficacy & Pharmacokinetics of Elamipretide in Subjects With AMD With Non-central GA — Completed
• Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations — Completed
• Study of Magrolimab (Hu5F9-G4) in Combination With Avelumab in Solid Tumor Participants and Checkpoint-Inhibitor-Naive Ovarian Cancer Participants Who Progress Within 6 Months of Prior Platinum Chemotherapy — Completed
• Ketogenic Diet in Rheumatoid Arthritis (RA) — Enrolling by invitation
• Smoking Cessation for Cervical Cancer Survivors — Completed
• A Study of Sapanisertib, Combination of Sapanisertib With MLN1117, Paclitaxel and Combination of Sapanisertib With Paclitaxel in Women With Endometrial Cancer — Completed
• Safety and Pharmacology Study of Atezolizumab Alone and in Combination With Bacille Calmette-Guérin (BCG) in High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) Participants — Stopped early
• A Study to Evaluate the Safety, Pharmacokinetics and Clinical Activity of RO6870810 and Atezolizumab (PD-L1 Antibody) in Participants With Advanced Ovarian Cancer or Triple Negative Breast Cancer — Stopped early
• A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis — Stopped early
• Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease — Stopped early
• Hydrogel Endovascular Aneurysm Treatment Trial — Completed
• Study of Room Air Versus 60% Oxygen for Resuscitation of Premature Infants — Stopped early
• A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) — Completed
• Clazosentan in Aneurysmal Subarachnoid Hemorrhage — Stopped early
• A Study Evaluating the Safety and Pharmacokinetics of DMUC4064A in Participants With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer — Completed
• A Study of DNIB0600A in Comparison With Pegylated Liposomal Doxorubicin (PLD) in Participants With Platinum-Resistant Ovarian Cancer (PROC) — Stopped early
• Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke — Stopped early
• The SOX Trial: Compression Stockings to Prevent the Post-Thrombotic Syndrome — Completed
• Biomarker Sub Study of the Compression Stockings to Prevent the Post-Thrombotic Syndrome (SOX) Trial — Completed
• Warming Mattress Versus Polyethylene Wrapping to Prevent Hypothermia in Preterm Newborns. — Completed
• High Intensity Focused Ultrasound (HIFU) Ablation System Study — Paused
• Clinical Trial for Ovarian Cancer (OvaRex®) — Stopped early